Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Colorcon
Johnson and Johnson
McKesson
Express Scripts

Last Updated: May 29, 2022

CLINICAL TRIALS PROFILE FOR FENTANYL CITRATE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Fentanyl Citrate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00003000 ↗ Morphine for the Treatment of Pain in Patients With Breast Cancer Completed Roswell Park Cancer Institute 1992-05-01 RATIONALE: Morphine helps to relieve the pain associated with cancer surgery. Giving morphine in different ways may offer more pain relief. PURPOSE: This randomized clinical trial is studying how well morphine injected directly into the underarm area works compared with morphine injected into the back of the shoulder in treating pain in patients who have breast cancer and who are undergoing axillary lymph node dissection.
NCT00105287 ↗ Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients Completed Cephalon Phase 3 2005-01-01 The purpose of this study is to evaluate the safety and tolerability of OraVescent fentanyl when used long-term to relieve breakthrough pain in opioid tolerant cancer patients.
NCT00105937 ↗ OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients Completed Cephalon Phase 3 2004-04-01 The purpose of this study is to evaluate the long-term safety and efficacy of OraVescent fentanyl to treat breakthrough pain episodes in cancer patients who are already opioid tolerant.
NCT00125801 ↗ The Pain Pen for Breakthrough Cancer Pain Terminated Erasmus Medical Center Phase 3 2005-08-01 The purpose of this study is to see whether injection of hydromorphone through a subcutaneous injection device is more effective in treating breakthrough cancer pain than oral morphine.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Fentanyl Citrate

Condition Name

Condition Name for Fentanyl Citrate
Intervention Trials
Pain 23
Cancer 9
Breakthrough Pain 5
Postoperative Pain 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Fentanyl Citrate
Intervention Trials
Breakthrough Pain 16
Pain, Postoperative 8
Cancer Pain 6
Dyspnea 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Fentanyl Citrate

Trials by Country

Trials by Country for Fentanyl Citrate
Location Trials
United States 198
Canada 8
Egypt 6
India 6
China 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Fentanyl Citrate
Location Trials
New York 14
California 12
Texas 11
Florida 10
North Carolina 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Fentanyl Citrate

Clinical Trial Phase

Clinical Trial Phase for Fentanyl Citrate
Clinical Trial Phase Trials
Phase 4 23
Phase 3 23
Phase 2/Phase 3 1
[disabled in preview] 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Fentanyl Citrate
Clinical Trial Phase Trials
Completed 59
Unknown status 12
Terminated 12
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Fentanyl Citrate

Sponsor Name

Sponsor Name for Fentanyl Citrate
Sponsor Trials
Cephalon 11
Eisai Inc. 8
PPD 5
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Fentanyl Citrate
Sponsor Trials
Other 77
Industry 54
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Mallinckrodt
Moodys
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.